Etsi sivustostamme
First Hevylite™ assays are available
Hevylite epitopesBinding Site announces the launch of Hevylite™. This novel immunoassay panel is designed for analysis of immunoglobulin heavy chain/light chain pairs. As with Freelite™, of which Binding Site sells 5 million tests worldwide, Hevylite will be used in monitoring patients with
Multiple Myeloma and other B cell dyscrasias.
Diagnostiikka-uutuuksia
Real-Time PCR testejä sikainfluenssan (influenssavirus A/H1N1) diagnostiikkaan
Leuko64™ This routine diagnostic kit detects systemic inflammation and tissue injury by measuring the differences in CD64 expression on leukocyte.
SuPARnostic ® is the ideal tool for predicting and managing patient survival. This prognostic assay is based on differences of suPAR levels in blood.
sTREM-1 is a diagnostic marker for sepsis and inflammation. It can indicate a pneumonia but is also described as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age.
Neopterin. Increased levels provide early predictive information for development of sepsis, multiple organ failure and death. Acute virus infections highly correlate with an increased neopterin concentration.
Macro163. Measuring the levels of the biomarker soluble CD163 by ELISA is a proven (prognostic) methodology for the presence of sepsis and liver failure. It also is a potential diagnostic tool for the life-threatening Macrophage Activation Syndrome.